Ticker: ATRA

Company Overview: Atara Biotherapeutics, Inc. (NASDAQ: ATRA) is a leader in T-cell immunotherapy, focusing on developing transformative therapies for patients with cancer and autoimmune diseases. The company's lead program, tab-cel (tabelecleucel), has received marketing authorization in certain ...